NSF Pharma Biotech Conference 2026
Join NSF in London for the fourth annual Pharma Biotech Conference as the industry explores how to move from compliance to resilience and build quality systems that withstand disruption.

Date: Thursday 19th November 2026
Venue: The Royal Society of Chemistry, Burlington House, Piccadilly, London, United Kingdom
About the Conference
NSF is pleased to announce its 4th annual Pharma Biotech Conference, taking place on 19 November 2026 at the Royal Society of Chemistry in London. Building on the success of the 2023, 2024 and 2025 events, this year's conference returns with its most ambitious and forward-looking program yet and forms part of the inaugural NSF Summit Series.
This year's theme is "From Compliance to Resilience: How Companies Can Build Quality Systems That Withstand Disruption." Pharma and biotech organizations are operating in an environment shaped by geopolitical uncertainty, changing global trade dynamics, supply chain pressure, digital disruption, workforce challenges and increasing scrutiny around product quality and patient safety. The conference will explore how leaders can move beyond compliance and build quality systems, leadership approaches and operating models that remain effective under pressure.
What to expect
The conference will combine expert presentations, practical case studies, panel discussion and networking time designed for meaningful peer exchange. You will hear perspectives from NSF subject matter experts as well as invited industry speakers from global pharmaceutical companies, biotechnology organizations, CDMOs and regulatory bodies working at the sharp end of quality, validation, manufacturing and regulatory decision-making.
Why attend
Delegates will leave with practical, experience-led insight on strengthening quality systems, responding to regulatory uncertainty, learning from peer experience and preparing their teams for what comes next.
Who should attend
- Quality assurance and quality systems leaders
- Regulatory affairs professionals
- Validation and qualification specialists
- Manufacturing and operations leaders
- Compliance and auditing professionals
- Technical, clinical and supply chain decision-makers within pharma and biotech
Conference Agenda
| Time | Headline | Speaker / Abstract |
|---|---|---|
| 09:00 | Registration & Networking | Start the day with coffee, conversation and an opportunity to connect with fellow pharmaceutical and biotechnology professionals. |
| 09:50 | Welcome Address | Magdalena Müller, Director, Life Sciences EMEA, NSF Magdalena Müller will welcome attendees, introduce the conference theme and set the context for a day focused on quality, resilience, leadership and sustainable growth. |
| 10:00 | Navigating Uncertainty: The Regulatory and Market Forces Reshaping Pharmaceutical Quality | Dr. Peter Gough, NSF Pharmaceutical organizations must respond to changing regulatory expectations, supply chain pressures and accelerating innovation without losing control of quality or compliance. Dr. Peter Gough will examine the forces influencing the sector and highlight the issues quality leaders should be preparing for now.
What you’ll learn:
|
| 10:25 | Resilient Quality Leadership: Sustaining Performance Through Change | Breda Quinn, Reckitt Quality leaders must maintain compliance and organizational alignment while supporting growth and navigating constant change. Drawing on senior leadership experience in regulated organizations, Breda Quinn will share practical approaches to keeping quality influential and effective during transformation.
You’ll gain practical insight into:
|
| 10:50 | Policy, Trade and the Global Landscape: What Quality Leaders Need to Prepare For | Raul Radoi, NSF Policy changes, international trade pressures and supply chain complexity can create new risks across pharmaceutical operations. Raul Radoi will explore how developments in the wider global landscape may affect quality strategy, compliance planning and organizational resilience.
Key insights:
|
| 11:20 | Networking Refreshment Break | Refresh, reconnect and continue the morning’s conversations with speakers and fellow attendees. |
| 11:50 | Building Quality Into Growth: Lessons From Scaling a Cell and Gene Therapy Operation | Emma Ewins, Exmoor Pharma Scaling advanced therapy operations can expose weaknesses in quality systems, governance and organizational capability. Drawing on her experience developing and leading a Cell and Gene Therapy manufacturing operation, Emma Ewins will share how quality can be embedded from the outset rather than added after growth has created gaps.
Take away practical approaches for:
|
| 12:15 | Lean Thinking for Sustainable Quality Performance | Steve Nicolls, The Lean Orange Complex and inefficient processes can undermine operational performance and quality outcomes. Steve Nicolls will explore how Lean thinking can help organizations simplify work, improve decision-making and create sustainable habits of continuous improvement. Steve Nicolls is listed as TBC in the working agenda.
The session will help you:
|
| 12:40 | Moderated Discussion: Turning Resilience Into Reality | Featuring the Morning Speakers Resilience can remain an abstract ambition unless it is translated into practical decisions, behaviors and operating models. The morning speakers will compare perspectives, examine implementation challenges and discuss what resilient quality leadership looks like in practice.
Discussion themes will include:
|
| 13:00 | Networking Lunch | Enjoy lunch while building new connections and continuing discussions with fellow attendees and presenters. |
| 14:00 | Building Resilient Organizations: Embedding Quality as a Strategic Capability | Catherine Kay, NSF Many organizations understand the importance of resilience but struggle to turn it into practical improvements in performance and decision-making. Catherine Kay will explore how quality, governance and risk management can work together as strategic capabilities rather than isolated compliance activities.
Key takeaways:
|
| 14:25 | Critical Success Factors for Implementing Strategic Quality Management in Times of Disruption | Nuno Furtado, Amicus Therapeutics Traditional quality systems may not provide the resilience organizations need during disruption and change. Drawing on Strategic Quality Management research and extensive pharmaceutical and biotechnology experience, Nuno Furtado will examine how quality can move beyond compliance and become a strategic business enabler.
You’ll explore how to:
|
| 14:50 | Networking Refreshment Break | Recharge and reconnect before the final sessions on future quality systems, innovation and growth. |
| 15:20 | From Compliance to Competitive Advantage: Future-Proofing Quality Systems | Marie O’Callaghan, NSF Quality systems must do more than demonstrate compliance. They must help organizations identify risk, make better decisions and respond effectively as regulatory and business conditions change. Marie O’Callaghan will explore how quality systems can evolve to deliver greater organizational value.
Practical learning points:
|
| 15:45 | From Startup to Strategic Partner: Building a Resilient Biotechnology Business | Amy Walker, 4basebio Biotechnology companies must balance scientific innovation with the operational discipline required to scale, attract investment and meet evolving expectations. Amy Walker will share lessons from the growth of 4basebio and explore how strategic focus, quality and resilience can support long-term progress.
Lessons from the case study:
|
| 16:10 | Panel Discussion: From Compliance to Resilience | Industry and NSF Expert Panel The final panel will bring together ideas from across the program and focus on what quality leaders must do next. Panellists will explore how organizations can respond to regulatory change, strengthen operational resilience and ensure quality remains relevant to future business needs.
The panel will consider:
|
| 16:35 | Closing Reflections | The day’s key lessons will be brought together into a concise set of priorities, helping you identify the ideas most relevant to your organization and role. |
| 16:50 | Event Close | The NSF Pharmaceutical & Biotech Conference 2026 concludes. |
Registration
Registration is now open. Reserve your place to join life sciences quality and regulatory professionals from across Europe for a day of practical insight, discussion and networking.
For questions about this event please contact us at [email protected]
How NSF Can Help You
Speak with NSF’s pharma biotech experts about regulatory, quality and market access challenges across global markets.
What’s New with NSF

NSF Hosts First External Review Panel for ‘NSF/KWTC 555’ with Key Asian Water Authorities
August 3, 2026Joint standard development gains momentum to enhance confidence in Asia’s water industry and advance drinking water safety.
NSF Achieves European Accreditation for Drinking Water Product Certification Ahead of 2027 EU Deadline
July 22, 2026The ISO/IEC 17065 accreditation from BELAC complements NSF’s testing capacity, enabling end-to-end support for EU Drinking Water Directive (DWD) readiness ahead of the January 2027 deadline.
Meet NSF at Fruit Attraction
July 15, 2026NSF is excited to be exhibiting at Fruit Attraction, a leading international trade fair for the fruit and vegetable sector.
NSF Awards World-First Community Catch Certification to Orkney Crab Fishery
July 13, 2026Milestone certification sets a new benchmark for small-scale fishery sustainability and social responsibility.